scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1042487130 |
P356 | DOI | 10.1038/EYE.2001.167 |
P698 | PubMed publication ID | 11767031 |
P5875 | ResearchGate publication ID | 11590843 |
P2093 | author name string | Cooper M | |
Chowers I | |||
Granot E | |||
Merin S | |||
Banin E | |||
P2860 | cites work | Red blood cell fatty acid levels in patients with autosomal dominant retinitis pigmentosa | Q72564966 |
The neuropathy of abetalipoproteinemia | Q72603694 | ||
Familial hypobetalipoproteinemia--differences in lipoprotein structure and composition | Q72780814 | ||
A-BETA-LIPOPROTEINAEMIA WITH SPECIAL REFERENCE TO THE VISUAL DEFECT | Q78321154 | ||
Changes produced by light in the standing potential of the human eye | Q79336034 | ||
Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia | Q24294711 | ||
Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia | Q28262033 | ||
Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia | Q33645105 | ||
Bassen-Kornzweig syndrome. Present status | Q34633861 | ||
Long-term management of abetalipoproteinaemia. Possible role for vitamin E | Q34989797 | ||
Hypocholesterolemia in childhood | Q38668950 | ||
Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia | Q41830444 | ||
Abetalipoproteinaemia in adults: role of vitamin therapy | Q43747702 | ||
Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiency | Q48350783 | ||
Ocular Motor Signs in Some Metabolic Diseases | Q50937666 | ||
VITAMIN E AND NEUROLOGICAL FUNCTION | Q56609576 | ||
Ophthalmoplegia and Dissociated Nystagmus in Abetalipoproteinemia | Q67447693 | ||
Electroretinographic Responses Following Vitamin A Therapy in A-Beta-Lipoproteinemia | Q69090763 | ||
Angioid streaks associated with abetalipoproteinemia. Case report | Q69265925 | ||
Neutral lipids of plasma and adipose tissue in a-betalipo-proteinaemia | Q71519855 | ||
Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia | Q72057191 | ||
Abnormal plasma lipids of patients with Retinitis pigmentosa | Q72319269 | ||
P433 | issue | Pt 4 | |
P921 | main subject | vitamin A | Q18225 |
abetalipoproteinemia | Q319812 | ||
retinal degeneration | Q3043268 | ||
P304 | page(s) | 525-530 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Eye | Q10278937 |
P1476 | title | Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients | |
P478 | volume | 15 |
Q42152035 | A Male Infant with Abetalipoproteinemia: A Case Report from Iran. |
Q38167282 | Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management |
Q34574677 | Abetalipoproteinemia in Israel: evidence for a founder mutation in the Ashkenazi Jewish population and a contiguous gene deletion in an Arab patient |
Q21202911 | Abetalipoproteinemia: two case reports and literature review |
Q35056603 | Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins |
Q33634096 | Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration |
Q33758267 | Cholesterol in the retina: the best is yet to come. |
Q42243027 | Clinical utility gene card for: Abetalipoproteinaemia |
Q36695239 | Clinical utility gene card for: Abetalipoproteinaemia--Update 2014. |
Q42243035 | Clinical utility gene card for: Familial Hypobetalipoproteinaemia (APOB). |
Q36695217 | Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014. |
Q37712100 | Clinical, hematological, and imaging observations in a 25-year-old woman with abetalipoproteinemia |
Q36711327 | Common and rare gene variants affecting plasma LDL cholesterol |
Q33587865 | Dosage and formulation issues: oral vitamin E therapy in children |
Q39213724 | EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. |
Q36217421 | Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review. |
Q90320486 | Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease |
Q37169928 | Establishment of reference values of α-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia |
Q50334933 | Familial hypobetalipoproteinemia |
Q36098448 | Familial hypobetalipoproteinemia-induced nonalcoholic steatohepatitis |
Q46208202 | Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases |
Q38267212 | Insights from human congenital disorders of intestinal lipid metabolism |
Q50514445 | Microsomal triglyceride transfer protein gene mutations in Turkish children: A novel mutation and clinical follow up. |
Q36359516 | Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism |
Q34682702 | Ophthaproblem. Vitamin A and vitamin E. |
Q40470219 | Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. |
Q57826004 | Soft Drusen in Age-Related Macular Degeneration: Biology and Targeting Via the Oil Spill Strategies |
Q35570546 | The eye in metabolic disease |
Q36787937 | The oil spill in ageing Bruch membrane |
Q38208223 | Update on primary hypobetalipoproteinemia |